Vaccines

04 Apr 2020 Update on GSK actions to support the global response to COVID-19
03 Apr 2020 Voltron Therapeutics, Inc. Enters into Sponsored Research Agreement with The Vaccine & Immunotherapy Center at the Massachusetts General Hospital to Develop Potential COVID-19 Vaccine
02 Apr 2020 Applied DNA and Takis Biotech Expand COVID-19 Vaccine Development Program to Include 5th Candidate
01 Apr 2020 Vaxart Provides Update on its Oral COVID-19 Vaccine Program
01 Apr 2020 VBI Vaccines Announces Collaboration with the National Research Council of Canada to Develop Pan-Coronavirus Vaccine Candidate Targeting COVID-19, SARS, and MERS
31 Mar 2020 Cobra Biologics and the Karolinska Institutet collaborate to develop COVID-19 vaccine
30 Mar 2020 Johnson & Johnson Announces a Lead Vaccine Candidate for COVID-19; Landmark New Partnership with U.S. Department of Health & Human Services; and Commitment to Supply One Billion Vaccines Worldwide for Emergency Pandemic Use
27 Mar 2020 Sanofi Pasteur and Translate Bio to Collaborate to Develop a Novel mRNA Vaccine Candidate Against COVID-19
26 Mar 2020 INOVIO Reports Positive Interim Phase 2 VGX-3100 Results In Patients with HPV-associated Anal Dysplasia
26 Mar 2020 Sorrento Launches Novel I-Cell™ COVID-19 Cellular Vaccine Program
26 Mar 2020 Dynavax and CEPI Announce Collaboration to Support Global Effort to Develop a Vaccine for Coronavirus (COVID-19)
26 Mar 2020 SutroVax Announces $110M Series D Financing to Advance Broadest-Spectrum Pneumococcal Vaccine Candidates to Prevent Pneumonia
25 Mar 2020 Sartorius Supports the Development of the First Vaccine Candidate Against the Novel Coronavirus to Enter Clinical Trials
25 Mar 2020 Akers Biosciences Acquires Licenses to Coronavirus Vaccine Candidate from Premas Biotech
24 Mar 2020 eTheRNA Launches an International Consortium and Starts Development of Cross-strain Protective CoV-2 mRNA Vaccine for High Risk Populations
24 Mar 2020 Ufovax successfully extended its Nanoparticle vaccine technology to SARS-CoV-2
24 Mar 2020 Dynavax and Clover Biopharmaceuticals Announce Research Collaboration to Evaluate Coronavirus (COVID-19) Vaccine Candidate with CpG 1018 Adjuvant
24 Mar 2020 Novavax’ NanoFlu Achieves All Primary Endpoints In Phase 3 Clinical Trial
23 Mar 2020 Hoth Therapeutics Announces Agreement to Joint Development for a Self-Assembling Vaccine (SAV) for the Potential Prevention of the Coronavirus (COVID-19)
23 Mar 2020 COVID-19 vaccine development
23 Mar 2020 Vaccitech and Oxford University Announce Promising Phase 2a Data on Prostate Cancer Immunotherapy
19 Mar 2020 CEPI collaborates with the Institut Pasteur in a consortium to develop COVID-19 vaccine
19 Mar 2020 SELLAS Announces Positive Antigen-Specific Immune Response Data for Nelipepimut-S (NPS) in Women with Ductal Carcinoma In Situ (DCIS) of the Breast from Phase 2 VADIS Study
19 Mar 2020 Versatope Selects Influenza Vaccine Candidate for Clinical Development
19 Mar 2020 Entos Pharmaceuticals Is Developing a DNA Vaccine Against COVID-19 Using Its Fusogenix Nanomedicine Platform

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2019 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up

Top